EdgarLookup
DEF 14A

DEF 14A Filing

Company
Arcturus Therapeutics Holdings Inc.
Filed
October 13, 2020
Period of Report
November 10, 2020
Accession Number
0001193805-20-001272

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →